PHI with Cerebral atheromatosis
How does this condition affect your private health insurance?
Cerebral atheromatosis, or atherosclerosis of the brain's blood vessels, is a chronic inflammatory process where plaque builds up in the arteries supplying the brain. This narrowing (stenosis) and hardening of arteries impede blood flow, leading to reduced oxygen and nutrient supply. It's a major cause of ischemic stroke and transient ischemic attacks (TIAs) due to clot formation or emboli. Progressive plaque accumulation can also lead to chronic cerebral hypoperfusion, contributing to vascular cognitive impairment. Risk factors include hypertension, high cholesterol, diabetes, smoking, and age. Early detection and management of these risk factors are crucial for prevention and slowing progression.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute events (TIA/stroke) range from minutes to hours for TIAs, and the acute phase of stroke management typically lasts days to weeks in hospital. Recovery and rehabilitation can span months to years.
Duration of Illness (Lifetime)
Chronic and progressive; it is a lifelong condition requiring ongoing management and surveillance for complications.
Cost of Treatment (Initial)
High. Includes emergency medical services, diagnostic imaging (CT/MRI), hospitalization, medications, and potential acute interventions (e.g., thrombolysis, thrombectomy). Costs can range from tens of thousands to over a hundred thousand USD.
Cost of Treatment (Lifetime)
Very high. Encompasses long-term medication, regular specialist follow-ups, extensive rehabilitation (physical, occupational, speech therapy), and potential future hospitalizations for recurrent events or complications. Costs can easily accumulate to hundreds of thousands USD over a lifetime.
Mortality Rate
Significant, especially if it leads to a severe stroke. Mortality rates for acute ischemic stroke can be around 10-20% within 30 days, increasing with stroke severity and patient comorbidities.
Risk of Secondary Damages
High. Common sequelae include motor deficits (e.g., hemiparesis), speech difficulties (e.g., aphasia), cognitive impairment (including vascular dementia), sensory disturbances, and psychological issues like depression and anxiety.
Probability of Full Recovery
Moderate to low after a significant event like a stroke. While some recovery is common, complete recovery without any residual neurological deficits is less frequent, estimated at 10-20% for stroke survivors.
Underlying Disease Risk
High. Zerebrale Atheromatose is strongly associated with other cardiovascular risk factors and diseases, including hypertension, dyslipidemia, diabetes mellitus, coronary artery disease, peripheral artery disease, obesity, and atrial fibrillation.